Poisoning associated with inappropriate use of a eutectic mixture of lidocaine and prilocaine before laser-assisted hair removal: about 3 cases
- PMID: 29785585
- DOI: 10.1007/s00414-018-1858-9
Poisoning associated with inappropriate use of a eutectic mixture of lidocaine and prilocaine before laser-assisted hair removal: about 3 cases
Abstract
Background: Eutectic mixtures of lidocaine and prilocaine are used during painful dermatological procedures. Poisoning is rarely reported in adults.
Material and method: We report three cases of women who experienced lidocaine and prilocaine poisoning after laser-assisted hair removal. Plasma levels of local anesthetics were assayed by a fully validated liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) method.
Case reports: The rules of application of the anesthetic cream were observed apart from the maximum dose and/or maximum surface area. One patient applied a higher dose than the maximum recommended dose (140 instead of 60 g) and all patients failed to comply with the maximum recommended surface area (600 cm2). The patients presented an unusual clinical pattern as compared with other local anesthetics overdose: signs of cardiac toxicity with no ECG changes or arrhythmia, neurological toxicity without seizures or coma, and methemoglobinemia.
Discussion: Health authorities should publish explicit recommendations targeting users and prescribers with particular emphasis on the maximal surface area of application.
Keywords: Laser-assisted hair removal; Lidocaine; Mass spectrometry; Methemoglobinemia; Prilocaine.
References
-
- Sobanko JF, Miller CJ, Alster TS (2012) Topical anesthetics for dermatologic procedures: a review. Dermatol Surg 38:709–721 - DOI
-
- Tran AN, Koo JY (2014) Risk of systemic toxicity with topical lidocaine/prilocaine: a review. J Drugs Dermatol 13:1118–1122 - PubMed
-
- Martin F, Cherif K, Gentili ME, Enel D, Abe E, Alvarez JC, Mazoit JX, Chauvin M, Bouhassira D, Fletcher D (2008) Lack of impact of intravenous lidocaine on analgesia, functional recovery, and nociceptive pain threshold after total hip arthroplasty. Anesthesiology 109:118–123 - DOI
-
- Orlando R (2004) Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function. Clin Pharmacol Ther 75:80–88 - DOI
-
- Oni G, Brown S, Burrus C, Grant L, Watkins J, Kenkel M, Barton F Jr, Kenkel J (2010) Effect of 4% topical lidocaine applied to the face on the serum levels of lidocaine and its metabolite, monoethylglycinexylidide. Aesthet Surg J 30:853–858 - DOI